In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018

This publication has 58 references indexed in Scilit:

• Analysis of Synthetic Cannabinoids Using High-Resolution Mass Spectrometry and Mass Defect Filtering: Implications for Nontargeted Screening of Designer Drugs
  Analytical Chemistry, 2012
• JWH-018 and JWH-073: Δ9-Tetrahydrocannabinol-Like Discriminative Stimulus Effects in Monkeys
  The Journal of Pharmacology and Experimental Therapeutics, 2012
• A survey study to characterize use of Spice products (synthetic cannabinoids)
  Drug and Alcohol Dependence, 2012
• Synthetic cannabinoid JWH-018 and psychosis: An explorative study
  Drug and Alcohol Dependence, 2011
• Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a Peripherally Restricted Cannabinoid CB1/CB2 Receptor Agonist, Inhibits Gastrointestinal Motility but Has No Effect on Experimental Colitis in Mice
  The Journal of Pharmacology and Experimental Therapeutics, 2010
• Discriminative stimulus properties of Δ9-tetrahydrocannabinol (THC) in C57Bl/6J mice
  European Journal of Pharmacology, 2009
• Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: A Potent, Orally Bioavailable Human CB₁/CB₂Dual Agonist with Antihyperalgesic Properties and Restricted Central Nervous System Penetration
  Journal of Medicinal Chemistry, 2007
• Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 Pathway
  Journal of Biological Chemistry, 2007
• 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects
  The Journal of Pharmacology and Experimental Therapeutics, 2004
• Pharmacological specificity of the discriminative stimulus effects of Δ9-tetrahydrocannabinol in rhesus monkeys
  Drug and Alcohol Dependence, 1995